Correlation Between Cheniere Energy and Esperion Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cheniere Energy and Esperion Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cheniere Energy and Esperion Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cheniere Energy Partners and Esperion Therapeutics, you can compare the effects of market volatilities on Cheniere Energy and Esperion Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cheniere Energy with a short position of Esperion Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cheniere Energy and Esperion Therapeutics.
Diversification Opportunities for Cheniere Energy and Esperion Therapeutics
0.81 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Cheniere and Esperion is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Cheniere Energy Partners and Esperion Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Esperion Therapeutics and Cheniere Energy is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cheniere Energy Partners are associated (or correlated) with Esperion Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Esperion Therapeutics has no effect on the direction of Cheniere Energy i.e., Cheniere Energy and Esperion Therapeutics go up and down completely randomly.
Pair Corralation between Cheniere Energy and Esperion Therapeutics
Considering the 90-day investment horizon Cheniere Energy is expected to generate 2.36 times less return on investment than Esperion Therapeutics. But when comparing it to its historical volatility, Cheniere Energy Partners is 3.61 times less risky than Esperion Therapeutics. It trades about 0.25 of its potential returns per unit of risk. Esperion Therapeutics is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest 183.00 in Esperion Therapeutics on September 2, 2024 and sell it today you would earn a total of 97.00 from holding Esperion Therapeutics or generate 53.01% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cheniere Energy Partners vs. Esperion Therapeutics
Performance |
| Timeline |
| Cheniere Energy Partners |
| Esperion Therapeutics |
Cheniere Energy and Esperion Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cheniere Energy and Esperion Therapeutics
The main advantage of trading using opposite Cheniere Energy and Esperion Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cheniere Energy position performs unexpectedly, Esperion Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Esperion Therapeutics will offset losses from the drop in Esperion Therapeutics' long position.| Cheniere Energy vs. Plains All American | Cheniere Energy vs. Hess Midstream Partners | Cheniere Energy vs. Plains GP Holdings | Cheniere Energy vs. Antero Midstream Partners |
| Esperion Therapeutics vs. Elanco Animal Health | Esperion Therapeutics vs. SIGA Technologies | Esperion Therapeutics vs. Catalent | Esperion Therapeutics vs. ANI Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |